Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI

ClinicalTrials.gov ID: NCT00546260

Public ClinicalTrials.gov record NCT00546260. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Trial to Evaluate Effect of Adjunctive Antiplatelet Therapy With Intravenous PRT060128, a Selective P2Y12-Receptor Inhibitor, Before Primary Percutaneous Intervention (PCI) in ST-Elevation Myocardial Infarction (STEMI) Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Safety and efficacy of adjunctive antiplatelet therapy prior to primary percutaneous intervention (PCI) in patients with ST-Elevation Myocardial Infarction (STEMI)

Study identification

NCT ID
NCT00546260
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alexion Pharmaceuticals, Inc.
Industry
Enrollment
70 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2007 (Type not available)
Primary completion
Jul 2008 (Actual)
Completion
Jul 2008 (Actual)
Last update posted
Jun 24, 2026

2007 – 2008

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
13
Facility City State ZIP Site status
Tallahassee Memorial Medical Center Tallahassee Florida 32308 —
Iowa Heart Center Des Moines Iowa 50314 —
University of Kentucky Hospital, Gill Heart Center Lexington Kentucky 40536 —
Maine Medical Center Portland Maine 04102 —
Washington Adventist Hospital Takoma Park Maryland 20912 —
Henry Ford Hospital Detroit Michigan 48202 —
Genesys Regional Medical Center Grand Blanc Michigan 48439 —
St. Joseph Mercy - Oakland Pontiac Michigan 48341 —
William Beaumont Hospital Royal Oak Michigan 48073 —
William Beaumont Hospital - Troy Cardiology Troy Michigan 48085 —
Lindner Clinical Trial Center Cincinnati Ohio 45219 —
Geisinger Medical Center Danville Pennsylvania 17822 —
The Heart Center Kingsport Tennessee 37660 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00546260, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00546260 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →